Search

Your selection

Clear all

Filter by content type

Filter by content year

News

Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program

November 5, 2025 - … Vaxart . Actual results may differ materially from those set forth in this press release due to the risks and … Vaxart . Actual results may differ materially from those set forth in this press release due to the risks and … Vaxart . Actual results may differ materially from those set forth in this press release due to the risks and …
News

Vaxart Appoints W. Mark Watson as Lead Independent Director

September 17, 2025 - … votes from its stockholders with respect to the proposal set forth in the Proxy Statement. Vaxart encourages all … votes from its stockholders with respect to the proposal set forth in the Proxy Statement. Vaxart encourages all … votes from its stockholders with respect to the proposal set forth in the Proxy Statement. Vaxart encourages all …
News

Vaxart Announces Adjournment of Special Meeting of Stockholders

September 8, 2025 - … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously …
News

Vaxart Announces Trading on OTCQX Best Market

July 8, 2025 - … before a Nasdaq Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Pursuant to … before a Nasdaq Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Pursuant to … before a Nasdaq Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Pursuant to …
News

Vaxart Announces Adjournment of Annual Meeting of Stockholders

June 2, 2025 - … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously …
News

Vaxart Announces Adjournment of Annual Meeting of Stockholders

May 21, 2025 - … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously …
News

Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine

May 14, 2025 - … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The …
Scroll to Top